Dr. Alan Buffenstein, M.D

NPI: 1639278104
Total Payments
$3,826
2024 Payments
$1,161
Companies
15
Transactions
115
Medicare Patients
81
Medicare Billing
$15,708

Payment Breakdown by Category

Food & Beverage$3,711 (97.0%)
Education$114.57 (3.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,711 105 97.0%
Education $114.57 10 3.0%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $769.10 37 $0 (2024)
ABBVIE INC. $419.80 7 $0 (2024)
Janssen Pharmaceuticals, Inc $416.62 14 $0 (2024)
Avanir Pharmaceuticals, Inc. $405.43 4 $0 (2017)
Neurocrine Biosciences, Inc. $389.77 6 $0 (2024)
Allergan Inc. $291.17 10 $0 (2019)
Otsuka America Pharmaceutical, Inc. $265.70 26 $0 (2019)
Alexion Pharmaceuticals, Inc. $250.00 2 $0 (2024)
Biohaven Pharmaceuticals, Inc. $152.69 2 $0 (2021)
Amgen Inc. $125.00 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,161 18 Neurocrine Biosciences, Inc. ($317.04)
2023 $457.34 9 AbbVie Inc. ($178.03)
2022 $176.91 8 Alkermes, Inc. ($103.66)
2021 $522.46 15 Alkermes, Inc. ($203.31)
2020 $132.47 7 Alkermes, Inc. ($89.60)
2019 $340.94 14 Allergan Inc. ($152.50)
2018 $455.86 25 Allergan Inc. ($138.67)
2017 $579.06 19 Avanir Pharmaceuticals, Inc. ($405.43)

All Payment Transactions

115 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/06/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $26.54 General
Category: CNS
11/25/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $35.03 General
Category: Neuroscience
09/13/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $42.09 General
Category: Neuroscience
08/22/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $171.61 General
Category: Neuropsychiatry
07/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.30 General
Category: NEUROSCIENCE
07/11/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Rare Disease
06/10/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $29.67 General
Category: CNS
06/07/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $35.32 General
Category: Neuroscience
06/07/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $3.20 General
Category: Neuroscience
06/06/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $145.43 General
Category: Neuropsychiatry
05/17/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $128.04 General
Category: Neuroscience
04/16/2024 SK Life Science, Inc. XCOPRI (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Neurology
04/13/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $34.85 General
Category: NEUROSCIENCE
04/08/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $28.33 General
Category: Neuroscience
04/03/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $27.60 General
Category: CNS
02/22/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Rare Disease
01/31/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.56 General
Category: NEUROSCIENCE
01/26/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $41.00 General
Category: BOTOX THERAPEUTIC
11/03/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $27.99 General
Category: CNS
07/14/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $23.56 General
Category: CNS
06/08/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.33 General
Category: NEUROSCIENCE
05/23/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $25.54 General
Category: CNS
04/24/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $29.81 General
Category: CNS
02/24/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $24.02 General
Category: CNS
01/28/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $152.70 General
Category: BOTOX THERAPEUTIC

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 27 95 $10,314 $5,077
2022 1 13 52 $5,445 $3,109
2021 2 30 106 $11,560 $5,852
2020 1 11 33 $3,455 $1,669
Total Patients
81
Total Services
286
Medicare Billing
$15,708
Procedure Codes
6

All Medicare Procedures & Services

6 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 16 60 $6,283 $3,463 55.1%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 11 35 $4,031 $1,614 40.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 13 52 $5,445 $3,109 57.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 17 62 $6,492 $3,643 56.1%
90833 Psychotherapy performed with evaluation and management visit, 30 minutes Office 2021 13 44 $5,068 $2,210 43.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 11 33 $3,455 $1,669 48.3%

About Dr. Alan Buffenstein, M.D

Dr. Alan Buffenstein, M.D is a Psychiatry healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639278104.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Buffenstein, M.D has received a total of $3,826 in payments from pharmaceutical and medical device companies, with $1,161 received in 2024. These payments were reported across 115 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,711).

As a Medicare-enrolled provider, Buffenstein has provided services to 81 Medicare beneficiaries, totaling 286 services with total Medicare billing of $15,708. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Other Specialties Geriatric Psychiatry, Pain Medicine
  • Location Honolulu, HI
  • Active Since 09/21/2006
  • Last Updated 02/01/2011
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1639278104

Products in Payments

  • ARISTADA (Drug) $707.03
  • INVEGA SUSTENNA (Drug) $389.98
  • INGREZZA (Drug) $389.77
  • ULTOMIRIS (Biological) $250.00
  • VRAYLAR (Drug) $242.90
  • ONZETRA Xsail (Drug) $228.19
  • BOTOX (Biological) $193.70
  • NURTEC ODT (Drug) $184.10
  • UBRELVY (Drug) $129.06
  • Aimovig (Biological) $125.00
  • BOTOX (Drug) $125.00
  • UPLIZNA (Drug) $125.00
  • XCOPRI (Drug) $125.00
  • ABILIFY MAINTENA (Drug) $124.43
  • NUEDEXTA (Drug) $100.71
  • REXULTI (Drug) $73.08
  • Aristada 441 mg (Drug) $62.07
  • AUSTEDO (Drug) $44.26
  • SPRAVATO (Drug) $26.64
  • BYSTOLIC (Drug) $20.31

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Honolulu